Standalone figures · ₹ crore
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 469 | 801 | |
| COGS | 31 | 91 |
| Gross profit | 438 | 710 |
| 313 | 360 | |
| 125 | 350 | |
| OPM % | 26.6% | 43.6% |
| Depreciation | 9 | 48 |
| Interest | 1 | 13 |
| 6 | 9 | |
| Profit before tax | 122 | 298 |
| Tax | 31 | 76 |
| Tax % | 25.7% | 25.4% |
| 91 | 222 | |
| PAT margin % | 19.3% | 27.7% |
| EPS (₹) | 36.5 | 17.9 |
| EPS adjusted (₹) | — | 17.9 |
| 3% | 25.2% | |
| Annual report | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | — | 25 |
| Reserves | — | 443 |
| — | 0 | |
| 328 | 205 | |
| Total equity & liabilities | 328 | 673 |
| 92 | 178 | |
| CWIP | — | 2 |
| Investments | 4 | 110 |
| 232 | 383 | |
| Total assets | 328 | 673 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 69 | 262 | |
| -70 | -211 | |
| -1 | -59 | |
| Net cash flow | -2 | -8 |
| Free cash flow | 27 | 229 |
| CFO / Operating profit % | 55% | 74.9% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Ayurvedic Products and Medicines | 415.68 | 164.74 | 0 | 0 |
| Ayurvedic Healthcare Services | 383.4 | 156.49 | 0 | 0 |
| others | 2.27 |
| 2.27 |
| 0 |
| 0 |
₹ crore by fiscal year